DCM
ARNA

Dialectic Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Dialectic Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,500
Closed -$659K – 210
2013
Q3 		$659K Buy
12,500
+8,633
+223% +$580K 0.15% 141
2013
Q2 		$298K Buy
+3,867
New +$316K 0.04% 171

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dialectic Capital Management's ARNA Position: Q4 2013 in Review

Dialectic Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2013, closing a stake of 12,500 shares — an estimated $659K sold.

Dialectic Capital Management first reported a position in ARNA in Q2 2013 and held it in 2 quarters. The position peaked at $659K in Q3 2013. 134 funds tracked by Wall St. Rank hold ARNA as of Q4 2013.

  • Dialectic Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Dialectic Capital Management sold 12,500 Arena Pharmaceuticals Inc shares in Q4 2013, an estimated $659K.
  • Dialectic Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Dialectic Capital Management's Arena Pharmaceuticals Inc position peaked at $659K in Q3 2013.
  • 134 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2013.

Based on Dialectic Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.